img

Global Glutamate Receptor Ionotropic NMDA 2B Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Glutamate Receptor Ionotropic NMDA 2B Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Glutamate Receptor Ionotropic NMDA 2B report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Glutamate Receptor Ionotropic NMDA 2B market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Acute Ischemic Stroke and Autism are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Glutamate Receptor Ionotropic NMDA 2B industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Glutamate Receptor Ionotropic NMDA 2B key manufacturers include BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG and UCB S.A., etc. BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc. are top 3 players and held % sales share in total in 2022.
Glutamate Receptor Ionotropic NMDA 2B can be divided into JNJ-0808, Neu-2000, NP-10679 and NP-11948, etc. JNJ-0808 is the mainstream product in the market, accounting for % sales share globally in 2022.
Glutamate Receptor Ionotropic NMDA 2B is widely used in various fields, such as Acute Ischemic Stroke, Autism, Brain Ischemia and Burns, etc. Acute Ischemic Stroke provides greatest supports to the Glutamate Receptor Ionotropic NMDA 2B industry development. In 2022, global % sales of Glutamate Receptor Ionotropic NMDA 2B went into Acute Ischemic Stroke filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glutamate Receptor Ionotropic NMDA 2B market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
Segment by Type
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others

Segment by Application


Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Glutamate Receptor Ionotropic NMDA 2B market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Glutamate Receptor Ionotropic NMDA 2B, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Glutamate Receptor Ionotropic NMDA 2B industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Glutamate Receptor Ionotropic NMDA 2B in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Glutamate Receptor Ionotropic NMDA 2B introduction, etc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Glutamate Receptor Ionotropic NMDA 2B market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Glutamate Receptor Ionotropic NMDA 2B Market Overview
1.1 Glutamate Receptor Ionotropic NMDA 2B Product Overview
1.2 Glutamate Receptor Ionotropic NMDA 2B Market Segment by Type
1.2.1 JNJ-0808
1.2.2 Neu-2000
1.2.3 NP-10679
1.2.4 NP-11948
1.2.5 Radiprodil
1.2.6 Others
1.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
1.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Overview by Type (2018-2034)
1.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Historic Market Size Review by Type (2018-2024)
1.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Type (2018-2024)
1.4.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Type (2018-2024)
2 Global Glutamate Receptor Ionotropic NMDA 2B Market Competition by Company
2.1 Global Top Players by Glutamate Receptor Ionotropic NMDA 2B Sales (2018-2024)
2.2 Global Top Players by Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2024)
2.3 Global Top Players by Glutamate Receptor Ionotropic NMDA 2B Price (2018-2024)
2.4 Global Top Manufacturers Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base Distribution, Sales Area, Product Type
2.5 Glutamate Receptor Ionotropic NMDA 2B Market Competitive Situation and Trends
2.5.1 Glutamate Receptor Ionotropic NMDA 2B Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glutamate Receptor Ionotropic NMDA 2B as of 2022)
2.7 Date of Key Manufacturers Enter into Glutamate Receptor Ionotropic NMDA 2B Market
2.8 Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Glutamate Receptor Ionotropic NMDA 2B Status and Outlook by Region
3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Glutamate Receptor Ionotropic NMDA 2B Historic Market Size by Region
3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2018-2024)
3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region (2018-2024)
3.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Region
3.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2024-2034)
3.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region (2024-2034)
3.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Glutamate Receptor Ionotropic NMDA 2B by Application
4.1 Glutamate Receptor Ionotropic NMDA 2B Market Segment by Application
4.1.1 Acute Ischemic Stroke
4.1.2 Autism
4.1.3 Brain Ischemia
4.1.4 Burns
4.1.5 Others
4.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Overview by Application (2018-2034)
4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Historic Market Size Review by Application (2018-2024)
4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Application (2018-2024)
4.3.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Application (2018-2024)
5 North America Glutamate Receptor Ionotropic NMDA 2B by Country
5.1 North America Glutamate Receptor Ionotropic NMDA 2B Historic Market Size by Country
5.1.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2018-2024)
5.1.3 North America Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2018-2024)
5.2 North America Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Country
5.2.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2024-2034)
5.2.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2024-2034)
6 Europe Glutamate Receptor Ionotropic NMDA 2B by Country
6.1 Europe Glutamate Receptor Ionotropic NMDA 2B Historic Market Size by Country
6.1.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2018-2024)
6.1.3 Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2018-2024)
6.2 Europe Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Country
6.2.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2024-2034)
6.2.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2024-2034)
7 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B by Region
7.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Historic Market Size by Region
7.1.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Region
7.2.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region (2024-2034)
8 Latin America Glutamate Receptor Ionotropic NMDA 2B by Country
8.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Historic Market Size by Country
8.1.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2018-2024)
8.1.3 Latin America Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2018-2024)
8.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Country
8.2.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2024-2034)
8.2.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2024-2034)
9 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B by Country
9.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Historic Market Size by Country
9.1.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Country
9.2.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 BioCrea GmbH
10.1.1 BioCrea GmbH Company Information
10.1.2 BioCrea GmbH Introduction and Business Overview
10.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
10.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Products Offered
10.1.5 BioCrea GmbH Recent Development
10.2 Bristol-Myers Squibb Company
10.2.1 Bristol-Myers Squibb Company Company Information
10.2.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Products Offered
10.2.5 Bristol-Myers Squibb Company Recent Development
10.3 Cerecor Inc.
10.3.1 Cerecor Inc. Company Information
10.3.2 Cerecor Inc. Introduction and Business Overview
10.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Products Offered
10.3.5 Cerecor Inc. Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Luc Therapeutics, Inc.
10.5.1 Luc Therapeutics, Inc. Company Information
10.5.2 Luc Therapeutics, Inc. Introduction and Business Overview
10.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Products Offered
10.5.5 Luc Therapeutics, Inc. Recent Development
10.6 NeurOp, Inc
10.6.1 NeurOp, Inc Company Information
10.6.2 NeurOp, Inc Introduction and Business Overview
10.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
10.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Products Offered
10.6.5 NeurOp, Inc Recent Development
10.7 Novartis AG
10.7.1 Novartis AG Company Information
10.7.2 Novartis AG Introduction and Business Overview
10.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Products Offered
10.7.5 Novartis AG Recent Development
10.8 UCB S.A.
10.8.1 UCB S.A. Company Information
10.8.2 UCB S.A. Introduction and Business Overview
10.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
10.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Products Offered
10.8.5 UCB S.A. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Glutamate Receptor Ionotropic NMDA 2B Industrial Chain Analysis
11.4 Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
11.4.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
11.4.2 Glutamate Receptor Ionotropic NMDA 2B Market Drivers
11.4.3 Glutamate Receptor Ionotropic NMDA 2B Market Challenges
11.4.4 Glutamate Receptor Ionotropic NMDA 2B Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
12.3 Glutamate Receptor Ionotropic NMDA 2B Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of JNJ-0808
Table 2. Major Company of Neu-2000
Table 3. Major Company of NP-10679
Table 4. Major Company of NP-11948
Table 5. Major Company of Radiprodil
Table 6. Major Company of Others
Table 7. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2024) & (K Pcs)
Table 9. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2024) & (US& Million)
Table 11. Global Glutamate Receptor Ionotropic NMDA 2B Market Share in Value by Type (2018-2024)
Table 12. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2024-2034) & (K Pcs)
Table 14. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type (2024-2034)
Table 17. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2024) & (K Pcs)
Table 19. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Type (2018-2024)
Table 21. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Company (2018-2024) & (K Pcs)
Table 29. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Company (2018-2024)
Table 30. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Company (2018-2024)
Table 32. Global Market Glutamate Receptor Ionotropic NMDA 2B Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global Glutamate Receptor Ionotropic NMDA 2B Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glutamate Receptor Ionotropic NMDA 2B as of 2022)
Table 36. Date of Key Manufacturers Enter into Glutamate Receptor Ionotropic NMDA 2B Market
Table 37. Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2018-2024) & (K Pcs)
Table 41. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Region (2018-2024)
Table 44. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2024-2034) & (K Pcs)
Table 46. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Region (2024-2034)
Table 49. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) & (K Pcs)
Table 52. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application (2018-2024)
Table 55. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2024-2034) & (K Pcs)
Table 57. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application (2024-2034)
Table 60. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) (K Pcs)
Table 62. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) (K Pcs)
Table 64. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (K Pcs)
Table 72. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Country (2018-2024)
Table 75. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (K Pcs)
Table 76. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Country (2024-2034)
Table 111. BioCrea GmbH Company Information
Table 112. BioCrea GmbH Introduction and Business Overview
Table 113. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product
Table 115. BioCrea GmbH Recent Development
Table 116. Bristol-Myers Squibb Company Company Information
Table 117. Bristol-Myers Squibb Company Introduction and Business Overview
Table 118. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product
Table 120. Bristol-Myers Squibb Company Recent Development
Table 121. Cerecor Inc. Company Information
Table 122. Cerecor Inc. Introduction and Business Overview
Table 123. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product
Table 125. Cerecor Inc. Recent Development
Table 126. Johnson & Johnson Company Information
Table 127. Johnson & Johnson Introduction and Business Overview
Table 128. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product
Table 130. Johnson & Johnson Recent Development
Table 131. Luc Therapeutics, Inc. Company Information
Table 132. Luc Therapeutics, Inc. Introduction and Business Overview
Table 133. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product
Table 135. Luc Therapeutics, Inc. Recent Development
Table 136. NeurOp, Inc Company Information
Table 137. NeurOp, Inc Introduction and Business Overview
Table 138. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 139. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product
Table 140. NeurOp, Inc Recent Development
Table 141. Novartis AG Company Information
Table 142. Novartis AG Introduction and Business Overview
Table 143. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 144. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product
Table 145. Novartis AG Recent Development
Table 146. UCB S.A. Company Information
Table 147. UCB S.A. Introduction and Business Overview
Table 148. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 149. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product
Table 150. UCB S.A. Recent Development
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Glutamate Receptor Ionotropic NMDA 2B Market Trends
Table 154. Glutamate Receptor Ionotropic NMDA 2B Market Drivers
Table 155. Glutamate Receptor Ionotropic NMDA 2B Market Challenges
Table 156. Glutamate Receptor Ionotropic NMDA 2B Market Restraints
Table 157. Glutamate Receptor Ionotropic NMDA 2B Distributors List
Table 158. Glutamate Receptor Ionotropic NMDA 2B Downstream Customers
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Glutamate Receptor Ionotropic NMDA 2B Product Picture
Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Glutamate Receptor Ionotropic NMDA 2B Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of JNJ-0808
Figure 6. Global JNJ-0808 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Neu-2000
Figure 8. Global Neu-2000 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of NP-10679
Figure 10. Global NP-10679 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of NP-11948
Figure 12. Global NP-11948 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Radiprodil
Figure 14. Global Radiprodil Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type in 2022 & 2034
Figure 19. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type in 2022
Figure 20. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type in 2022
Figure 21. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type in 2022
Figure 22. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type in 2022
Figure 25. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Glutamate Receptor Ionotropic NMDA 2B Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Glutamate Receptor Ionotropic NMDA 2B Revenue in 2022
Figure 31. Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Acute Ischemic Stroke
Figure 33. Global Acute Ischemic Stroke Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Autism
Figure 35. Global Autism Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Brain Ischemia
Figure 37. Global Brain Ischemia Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Burns
Figure 39. Global Burns Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 42. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application in 2022 & 2034
Figure 44. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application in 2022
Figure 45. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application in 2022
Figure 46. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application in 2022
Figure 47. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application in 2022
Figure 50. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Glutamate Receptor Ionotropic NMDA 2B Manufacturing Cost Structure
Figure 55. Glutamate Receptor Ionotropic NMDA 2B Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed